Fang, Wenkui Ken,Wang, Liming,Corpuz, Evelyn G.,Chow, Ken,Im, Wha Bin
申请号：
AU2010300791
公开号：
AU2010300791A1
申请日:
2010.09.28
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and or antagonist biological activity, wherein these compounds selected from the group consisting of wherein A, B, C, D, X, Y, Z and R are defined in the specification. Said compounds are useful for treating a disease or condition of a mammal selected from the group consisting of ocular diseases； systemic vascular barrier related diseases； allergies and other inflammatory diseases； cardiac diseases or conditions； fibrosis； pain and wounds.
